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The Place of Transluminal
Coronary Angioplasty in the
Management of Variant Angina:
A Warning*
MARTIN J. FRANK, MD, FACC
Augusta, Georgia
It is now generally accepted that both fixed and dynamic
coronary artery narrowing contribute to the origin of myo-
cardial ischemia in the majority of patients. However, it is
my belief that use of the term "variant angina" should be
restricted to patients reporting ischemic chest pain occurring
at rest or during ordinary activity, not related to the intensity
of exertion and without limitation of exercise tolerance be-
cause of pain. Within this definition it is important to dis-
tinguish between two groups of patients: those with a long
history of nonexertional angina without angina of effort or
previous infarction and those with recent onset severe chest
pain at rest, most commonly preceded by effort angina or
infarction, or both (1), The former group will almost in-
variably be found to have normal or near normal coronary
arteriograms, whereas the latter will have hemodynamically
important proximal stenoses of one or more coronary ar-
teries. In almost all cases the ambulatory or rest electro-
cardiogram will reveal ST segment elevation or depression
during episodes of pain (2). I believe that the term" coronary
spasm" should be restricted to transient, profound coronary
narrowing which may be focal or diffuse. Spasm should be
diagnosed at angiography, during spontaneous attacks or
after provocation with ergonovine maleate, It is obvious
from the above definitions that coronary artery vasomotion
plays a variable role in the genesis of myocardial ischemia
among these patients (2).
Prevention and treatment of myocardial ischemia. The
goal of therapy for patients with proven coronary artery
spasm should be the prevention of myocardial ischemia
rather than the prevention of recurrent attacks of angina,
because myocardial ischemia can occur in the absence of
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chest pain (3). This requires careful monitoring over time
for ST segment shifts. In these patients, the identification
of multiple episodes of myocardial ischemia, some of which
are asymptomatic, suggests a variable degree of reversible
narrowing, Management of the unstable patient should be
started with intravenous nitroglycerin. Long-acting sublin-
gual, oral or topical nitrates are also of demonstrated effi-
cacy, but should be reserved for the less acutely ill patient
and for those who have been stabilized by intravenous ther-
apy. Selective beta-blocking drugs may be used cautiously
in patients already taking a vasodilating agent. The slow
(calcium) channel blockers are extremely potent coronary
vasodilating agents and are very effective in the treatment
of variant angina. However, patients with associated hemo-
dynamically important and fixed proximal obstructions may
also benefit from coronary angioplasty. How should these
patients be selected?
Role of coronary angioplasty. Percutaneous translu-
minal coronary angioplasty was introduced as a treatment
for coronary artery disease in 1977 (4). Angioplasty is cur-
rently considered to be the treatment of choice for patients
with significant disability, despite adequate medical therapy,
who have proximal, severe single vessel disease. Experience
has proven the procedure to be effective and relatively safe
in properly selected patients when performed by experienced
operators. Bredlau et al. (5) prospectively recorded all in-
hospital complications of the first 3,500 consecutive patients
to undergo elective angioplasty at Emory University Hos-
pital. Multiple lesion angioplasty was performed in only
II %. Isolated, minor complications occurred in 6.9%, and
major complications (emergency surgery, myocardial in-
farction or death) were observed in 4.1 %. There were two
surgical and two nonsurgical deaths, giving a total mortality
of 0.1 %. About twice this number of major complications
and several times the number of deaths can be expected in
less experienced hands (6,7),
Angioplasty in fixed versus dynamic coronary ste-
nosis. The qualitative interpretation of coronary stenosis
assessed by percent reduction of luminal diameter correlates
poorly with the physiologic effect of stenosis, as assessed
by the reactive hyperemic response of coronary flow velocity
(Doppler technique) at operation after 20 seconds of coro-
nary artery occlusion (8). Both overestimation and under-
estimation of lesions with less than 60% stenosis are com-
mon. Underestimation of lesion severity occurs in 95% of
vessels with greater than 60% stenosis. This has particular
pertinence to the study by Bertrand et al. (9) in this issue
of the Journal. They compared the results of percutaneous
transluminal coronary angioplasty in a group of 132 patients
with fixed atherosclerotic narrowing and in a group of 97
patients with dynamic coronary stenosis (ergonovine-in-
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duced spasm superimposed on fixed stenosis). Sixty percent
or greater stenosis was used as the single anatomic criterion
for selection. All patients underwent follow-up angiogra-
phy. The rate of restenosis (defined as a loss of 50% of the
initial gain) was significantly higher in patients with com-
bined fixed and dynamic coronary stenosis (35 versus 22%,
p < 0.05). In addition, patients with fixed stenosis alone
were more apt to remain asymptomatic after restenosis than
those with combined fixed and dynamic narrowing (38 ver-
sus 15%).
Because visual interpretation of the coronary arteriogram
may not accurately predict the physiologic importance of a
fixed coronary stenosis, the decision to perform angioplasty
must be made with great care and can be made more accurate
if minimal cross-sectional area can be measured as well as
percentage narrowing (10). The additional problem in pa-
tients with variant angina and combined fixed and dynamic
narrowing is to determine what part of the visualized ob-
struction is reversible by intravenous or intracoronary ni-
troglycerin and which part is not. The study of Bertrand et
al. has contributed to our understanding of the potential
benefits of percutaneous transluminal coronary angioplasty
in patients with fixed and dynamic stenosis. However, the
selection of patients and the results of the study might have
been different if absolute diameter at the site of narrowing
and pressure gradients had been measured before and after
the intracoronary administration of nitroglycerin in patients
with a dynamic component to stenosis.
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